


PUBLICATIONS

p53: 800 million years of evolution and 40 years of discovery
Levine AJ
Nature Reviews Cancer 20, 471-480 (2020)
Targeting p53 pathways: mechanisms, structures, and advances in therapy
Wang H, Guo M, Wei H, Chen Y
Signal Transduction and Targeted Therapy 8, 92 (2023)
Drugging p53 in cancer, one protein, many targets
Hassin O, Oren M
Nature Reviews 22, 127-144 (2023)
"Magishe Kugel" Against Cancer
Tendler Y, Tendler A, Panshin A
J Mol Oncol Res 5(2),10-12 (2021)
Drugs Targeting p53 Mutations with FDA Approval and in Clinical Trials
Nishikawa S, Iwakuma T
Cancers 14, 429 (2023)

A review on exosomes application in clinical trials: perspective, questions, and challenges
Rezaie J, Feghhi M, Etemadi T
Cell Communication and Signaling 20, 145 (2022)
Overview and Update on Extracellular Vesicles: Considerations on Exosomes and Their Application in Modern Medicine
Di Bella MA
Biology 11, 804 (2022)
Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells
Zhu X, Badawia M, Pomeroy S, et al
Journal of extracellular vesicles vol. 6, 1324730 (2017)
New advances in exosome-based targeted drug delivery systems
Ferreira D, Moreira JN, Rodrigues LR
Critical Reviews in Oncology/Hematology 1036, 20 (2022)

Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Bray F, Laversanne M, Sung H, et al
Cancer J Clin 74, 229–263 (2024)